ask="9.03"
ask_size="10100"
average_daily_volume="1806280"
bid="7.75"
bid_size="2000"
book_value="0.02"
change="+0.06"
change_from_200_day_moving_average="3.21"
change_from_50_day_moving_average="2.07"
change_from_52_week_high="-0.35"
change_From_52_week_low="6.32"
change_in_percent="+0.69%"
close="8.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.75"
ebitda="-48.12M"
eps_estimate_current_year="-0.68"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.66"
ex_dividend_date="N/A"
float_shares="50464000"
high="9.15"
high_52_weeks="9.15"
last_trade_date="3/16/2017"
last_trade_price="8.80"
last_trade_size="33958"
last_trade_time="4:00pm"
low="8.76"
low_52_weeks="2.48"
market_capitalization="650.80M"
moving_average_200_day="5.59"
moving_average_50_day="6.73"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.78"
open="8.84"
pe_ratio="N/A"
peg_ratio="-0.65"
percent_change_from_200_day_moving_average="+57.53%"
percent_change_from_50_day_moving_average="+30.71%"
percent_change_from_52_week_high="-3.83%"
percent_change_from_52_week_low="+254.84%"
previous_close="8.74"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="416.19"
price_per_sales="24.53"
revenue="26.35M"
shares_outstanding="73955000"
short_ratio="5.21"
stock_exchange="NMS"
symbol="BCRX"
volume="1365852"
weeks_range_52="2.48 - 9.15"
